Magnetic resonance imaging determination of extraocular eye muscle volume in patients with thyroid-associated ophthalmopathy and proptosis

Acta Ophthalmologica Scandinavica

Volumn 84, Issue 3, 2006, Pages 419-423

  Kvetny, Jan ^a,c   Puhakka, Katriina Bøcker ^a   Røhl, Lisbeth ^b  

^a Esbjerg University Hospital   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c Hospital of Stoerstroem Country   (Denmark)

Author keywords

Magnetic resonance imaging; Proptosis; Thyroid associated ophthalmopathy; Thyrotropinreceptor antibodies

Indexed keywords

AUTOANTIBODY; THYROID HORMONE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN RECEPTOR ANTIBODY;

ADIPOSE TISSUE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; EDEMA; ENDOCRINE OPHTHALMOPATHY; EXOPHTHALMOS; EXTRAOCULAR MUSCLE; FEMALE; HUMAN; MUSCLE MASS; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; PATHOGENESIS; PRIORITY JOURNAL; THICKNESS;

ADULT; ANTITHYROID AGENTS; AUTOANTIBODIES; EXOPHTHALMOS; FEMALE; GRAVES OPHTHALMOPATHY; HUMANS; HYPERTROPHY; IODIDE PEROXIDASE; MAGNETIC RESONANCE IMAGING; METHIMAZOLE; OCULOMOTOR MUSCLES; RECEPTORS, THYROTROPIN; THYROID HORMONES; THYROTROPIN;

EID: 33646777759     PISSN: 13953907     EISSN: 16000420     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2005.00617.x     Document Type: Article

References (14)

1. Bahn RS (2002): Thyrotropin receptor expression in orbital adipose/ connective tissues from patients with thyroid-associated ophthalmopathy. Thyroid 12: 193-195.
2. Bahn RS (2003): Pathophysiology of GrTves' ophthalmopathy: the cycle of disease. J Clin Endocrinol Metab 88: 1936-1943.
3. Forbes G, Gorman CA, Brennam MD, Gehring DG, Ilstrup D & Earnest F (1986): Ophthalmopathy of GraCes' disease: computerized volume measurements of the orbital fat and muscle. Am J Neuroradiol 7: 751-756.
4. Gerding MN, Meer JWC, Broeninkn M, Bakker J, Wiersinga OWM & Prummel MF (2000a): Association of thyrotropin receptor antibodies with the clinical features of Graves' ophthalmopathy. Clin Endocrinol 52: 267-271.
5. Gerding MN, Prummel MF & Wiersinga WM (2000b): Assessment of disease activity in Graves' ophthalmopathy by orbital ultrasonography and clinical parameters. Clin Endocrinol 52: 641-646.
6. Hiromatsu Y, Kojima K, Ishisaka N, Tanaka K, Sato M, Nonaka K, Nishimura H & Nishida H (1992): Role of magnetic resonance imaging in thyroid-associated ophthalmopathy: Its predictive value for therapeutic outcome of immunosuppressive therapy. Thyroid 2: 299-305.
7. Mourits MP, Prummel MF, Wiersinga WM & Koornmeef L (1997): Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin Endocrinol 47: 9-14.
8. Nishida Y, Tian S, Isberg B, Hayashi O, Tallstedt L & Lennerstrand G (2002): Significance of orbital fatty tissue for exophthalmos in thyroid-associated ophthalmopathy. Graefes Arch Clin Exp Ophthalmol 240: 515-520.
9. Nishikawa M, Yoshimura M, Toyoda N et al. (1993): Correlation of orbital muscle changes evaluated by magnetic resonance imaging and thyroid-stimulating antibody in patients with Graves' ophthalmopathy. Acta Endocrinol 129: 213-219.
10. Szucs-Farkas Z, Toth J, Kollar J et al. (2005): Volume changes in intra- and extraorbital compartments in patients with Graves' ophthalmopathy: effect of smoking. Thyroid 15: 146-151.
11. Tian S, Nishida Y, Isberg B & Lennerstrand G (2000): MRI measurements of normal extraocular muscles and other orbital structures. Graefes Arch Clin Exp Ophthalmol 238: 393-404.
12. Villadolid MC, Yokohama N, Izumi M et al. (1995): Untreated Graves' disease patients without clinical ophthalmopathy demonstrate a high frequency of extraocular muscle (EOM) enlargement by magnetic resonance. J Clin Endocrinol Metab 80: 2830-2833.
13. Werner SC (1977): Modification of the classification of the eye changes of Graves' disease. Am J Ophthalmol 83: 725-727.
14. Zimmermann-Belsing T, Feldt-Rasmussen U & Fledelius HC (2002): Ultrasound measurement of the horizontal external eye muscles in patients with thyroid disease. Is orbital involvement associated with thyroid autoantibodies? Eur J Ophthalmol 12: 351-358.